Alzamend Neuro's Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. TLT
7. BETR
8. AMZN
9. LEN
10. APO

Go back to Alzamend Neuro's Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC
(NASDAQ: ALZN) Delayed: 1.84 +0.01 (0.55%)
Previous Close $1.83    52 Week High $ 
Open $1.83    52 Week Low $ 
Day High $1.84    P/E N/A 
Day Low $1.82    EPS $ 
Volume 18,627